A. Sethi

发表

Association of loss-of-function mutations in the ABCA1 gene with high-density lipoprotein cholesterol levels and risk of ischemic heart disease.

Børge G Nordestgaard, B. Nordestgaard, P. Schnohr, 2008, JAMA.

Lecithin: cholesterol acyltransferase--from biochemistry to role in cardiovascular disease.

A. Remaley, M. Amar, A. Sethi, 2009, Current opinion in endocrinology, diabetes, and obesity.

Effect of ACE insertion/deletion and 12 other polymorphisms on clinical outcomes and response to treatment in the life study

B. Nordestgaard, U. de Faire, Peggy H. Wong, 2010, Pharmacogenetics and genomics.

S1P, dihydro-S1P and C24:1-ceramide levels in the HDL-containing fraction of serum inversely correlate with occurrence of ischemic heart disease

B. Nordestgaard, A. Tybjaerg-hansen, A. Remaley, 2011, Lipids in Health and Disease.

Angiotensinogen Polymorphisms and Elevated Blood Pressure in the General Population: The Copenhagen City Heart Study

G. Jensen, A. Tybjærg‐Hansen, B. Nordestgaard, 2001, Hypertension.

Angiotensinogen Single Nucleotide Polymorphisms, Elevated Blood Pressure, and Risk of Cardiovascular Disease

G. Jensen, A. Tybjærg‐Hansen, R. Steffensen, 2003, Hypertension.

Angiotensinogen Gene Polymorphism, Plasma Angiotensinogen, and Risk of Hypertension and Ischemic Heart Disease: A Meta-Analysis

B. Nordestgaard, A. Tybjærg‐Hansen, A. Sethi, 2003, Arteriosclerosis, thrombosis, and vascular biology.

Association of apolipoprotein B and nuclear magnetic resonance spectroscopy-derived LDL particle number with outcomes in 25 clinical studies: assessment by the AACC Lipoprotein and Vascular Diseases Division Working Group on Best Practices.

A. Remaley, S. Devaraj, T. Cole, 2013, Clinical chemistry.

Angiotensinogen Mutations and Risk for Ischemic Heart Disease, Myocardial Infarction, and Ischemic Cerebrovascular Disease: Six CaseControl Studies from the Copenhagen City Heart Study

P. Schnohr, R. Steffensen, A. Sethi, 2001, Annals of Internal Medicine.

Angiotensinogen and ACE gene polymorphisms and risk of atrial fibrillation in the general population

M. Benn, G. Jensen, A. Tybjærg‐Hansen, 2008, Pharmacogenetics and genomics.

A New Equation for Calculation of Low-Density Lipoprotein Cholesterol in Patients With Normolipidemia and/or Hypertriglyceridemia.

A. Jaffe, R. Shamburek, A. Remaley, 2020, JAMA cardiology.

Asymmetry in the Lipid Affinity of Bihelical Amphipathic Peptides

D. Sviridov, H. Brewer, A. Remaley, 2008, Journal of Biological Chemistry.

Abstract 1690: Pre-Beta HDL and Lecithin:Cholesterol Acyltransferase Levels Are Strong Positive Diagnostic Risk Markers for Ischemic Heart Disease in Subjects with Both High and Low HDL-C Levels in the Copenhagen City Heart Study

A. Remaley, A. Tybjærg‐Hansen, M. Sampson, 2008 .

Preanalytical considerations in the design of clinical trials and epidemiological studies.

D. Morrow, C. Ellervik, M. Kellogg, 2015, Clinical chemistry.

&bgr;2-adrenergic receptor polymorphisms, asthma and COPD: two large population-based studies

B. Nordestgaard, M. Dahl, A. Tybjærg‐Hansen, 2011, European Respiratory Journal.

Structure/Function Relationships of Apolipoprotein A-I Mimetic Peptides: Implications for Antiatherogenic Activities of High-Density Lipoprotein

D. Sviridov, A. Murphy, A. Remaley, 2010, Circulation research.

164Ile allele in the &bgr;2-Adrenergic receptor gene is associated with risk of elevated blood pressure in women. The Copenhagen City Heart Study

G. Jensen, A. Tybjærg‐Hansen, B. Nordestgaard, 2005, Pharmacogenetics and genomics.

Apolipoprotein AI mimetic peptides: possible new agents for the treatment of atherosclerosis.

R. Shamburek, A. Remaley, M. Amar, 2007, Current opinion in investigational drugs.

SCARB1 Gene Variants Are Associated With the Phenotype of Combined High High-Density Lipoprotein Cholesterol and High Lipoprotein (a).

L. Becker, D. Becker, B. Nordestgaard, 2016, Circulation. Cardiovascular genetics.

Apolipoprotein B and cardiovascular disease risk: position statement from the AACC Lipoproteins and Vascular Diseases Division Working Group on Best Practices.

Sridevi Devaraj, Gyorgy Csako, S. Devaraj, 2009, Clinical chemistry.

Genetic Variation in Liver X Receptor Alpha and Risk of Ischemic Vascular Disease in the General Population

B. Nordestgaard, D. Kardassis, R. Frikke-Schmidt, 2011, Arteriosclerosis, thrombosis, and vascular biology.

164Ile allele in the b2-Adrenergic receptor gene is associated with risk of elevated blood pressure in women. The Copenhagen City Heart Study

G. Jensen, A. Tybjærg‐Hansen, B. Nordestgaard, 2005 .

High pre-beta1 HDL concentrations and low lecithin: cholesterol acyltransferase activities are strong positive risk markers for ischemic heart disease and independent of HDL-cholesterol.

Børge G Nordestgaard, B. Nordestgaard, A. Tybjaerg-hansen, 2010, Clinical chemistry.

High-density lipoprotein cholesterol efflux, nitration of apolipoprotein A-I, and endothelial function in obese women.

R. Cannon, A. Remaley, M. Gucek, 2012, The American journal of cardiology.

Genetic variation and activity of the renin-angiotensin system and severe hypoglycemia in type 1 diabetes.

P. Hougaard, S. Pramming, B. Thorsteinsson, 2008, The American journal of medicine.

Nanogen microelectronic chip for large-scale genotyping.

B. Nordestgaard, A. Tybjaerg-hansen, R. V. Andersen, 2004, Clinical chemistry.

A. Remaley, S. Devaraj, T. Cole, 2013, Clinical chemistry.

[Six case-control studies from the Osterbro-study (The Copenhagen City Heart Study). Angiotensinogen mutations and risk of myocardial and cerebral ischemia].

B. Nordestgaard, P. Schnohr, A. Tybjaerg-hansen, 2002, Lakartidningen.

Abstract 16602: Genetic Variation in Liver X Receptor Alpha Predicts Risk of Ischemic Vascular Disease in 60,000 Individuals from the General Population

B. Nordestgaard, R. Frikke-Schmidt, P. Grande, 2010 .